Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease


Por: E. KNECHT, O. CRIADO-GARCIA, C. AGUADO, J. GAYARRE, L. DURAN-TRIO, A. GARCIA-CABRERO, S. VERNIA, B. SAN MILLAN, M. HEREDIA, C. ROMA-MATEO, S. MOURON, L. JUANA-LOPEZ, M. DOMINGUEZ, C. NAVARRO, J. SERRATOSA, M. SANCHEZ, P. SANZ, P. BOVOLENTA and S. DE CORDOBA

Publicada: 1 abr 2012
Resumen:
Lafora disease (LD), a fatal neurodegenerative disorder characterized by intracellular inclusions called Lafora bodies (LBs), is caused by recessive loss-of-function mutations in the genes encoding either laforin or malin. Previous studies suggested a role of these proteins in regulating glycogen biosynthesis, in glycogen dephosphorylation and in the modulation of intracellular proteolytic systems. However, the contribution of each of these processes to LD pathogenesis is unclear. Here we review our recent finding that dysfunction of autophagy is a common feature of both laforin-and malin-deficient mice, preceding other pathological manifestations. We propose that autophagy plays a primary role in LD pathogenesis and is a potential target for its treatment.

Filiaciones:
:
 Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

O. CRIADO-GARCIA:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

:
 Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

J. GAYARRE:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

L. DURAN-TRIO:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

A. GARCIA-CABRERO:
 Fdn Jimenez Diaz, Inst Invest Sanitaria, Lab Neurol, E-28040 Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

S. VERNIA:
 CSIC, Inst Biomed Valencia, Valencia, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

B. SAN MILLAN:
 Complejo Hosp Univ Vigo Meixoeiro, Serv Anat Patol & Neuropatol, Vigo, Spain

M. HEREDIA:
 CSIC, Inst Biomed Valencia, Valencia, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

:
 CSIC, Inst Biomed Valencia, Valencia, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

S. MOURON:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

L. JUANA-LOPEZ:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

M. DOMINGUEZ:
 Inst Invest Carlos III, Ctr Nacl Microbiol, Serv Inmunol Microbiana, Majadahonda Madrid, Spain

C. NAVARRO:
 Complejo Hosp Univ Vigo Meixoeiro, Serv Anat Patol & Neuropatol, Vigo, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

J. SERRATOSA:
 Fdn Jimenez Diaz, Inst Invest Sanitaria, Lab Neurol, E-28040 Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

M. SANCHEZ:
 Fdn Jimenez Diaz, Inst Invest Sanitaria, Lab Neurol, E-28040 Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

P. SANZ:
 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

P. BOVOLENTA:
 Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

S. DE CORDOBA:
 CSIC, Ctr Invest Biol, Madrid, Spain

 Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
ISSN: 15548627





Autophagy
Editorial
TAYLOR & FRANCIS INC, 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106, Estados Unidos America
Tipo de documento: Editorial Material
Volumen: 8 Número: 4
Páginas: 701-703
WOS Id: 000305403400018
ID de PubMed: 22361617

MÉTRICAS